BRIEF-Bio-Rad Q3 Adjusted EPS USD 2.01 Vs. IBES Estimate USD 1.16

Reuters
31 Oct 2024
BRIEF-Bio-Rad Q3 Adjusted EPS USD 2.01 Vs. IBES Estimate USD 1.16

Oct 30 (Reuters) - Bio-Rad Q3 EPS USD 23.34.

  • Q3 gross margin 54.8%
  • Q3 EBIT margin 9.9%
  • Q3 net income USD 653.2 million
  • Q3 sales USD 649.7 million vs. IBES estimate USD 628.2 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10